Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) EBT Margin (2016 - 2025)

Historic EBT Margin for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to 1.7%.

  • Champions Oncology's EBT Margin fell 37800.0% to 1.7% in Q4 2025 from the same period last year, while for Oct 2025 it was 4.03%, marking a year-over-year increase of 52200.0%. This contributed to the annual value of 8.12% for FY2025, which is 226900.0% up from last year.
  • Latest data reveals that Champions Oncology reported EBT Margin of 1.7% as of Q4 2025, which was down 37800.0% from 3.23% recorded in Q3 2025.
  • In the past 5 years, Champions Oncology's EBT Margin registered a high of 26.52% during Q1 2025, and its lowest value of 20.96% during Q1 2024.
  • Moreover, its 5-year median value for EBT Margin was 1.8% (2021), whereas its average is 3.48%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by -250100bps in 2023, then surged by 474700bps in 2025.
  • Champions Oncology's EBT Margin (Quarter) stood at 2.45% in 2021, then crashed by -101bps to 0.01% in 2022, then crashed by -127001bps to 17.8% in 2023, then skyrocketed by 131bps to 5.48% in 2024, then crashed by -69bps to 1.7% in 2025.
  • Its last three reported values are 1.7% in Q4 2025, 3.23% for Q3 2025, and 15.9% during Q2 2025.